Healthy volunteers test new ginkgo-based injection for safety
NCT ID NCT07457008
First seen Mar 11, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This early-stage study tested the safety and tolerability of Ginkgolide B injection in 36 healthy Chinese adults aged 18 to 45. Participants received single or multiple doses to see how the drug moves through the body and whether it causes side effects. No treatment for any disease was given; the goal was simply to gather safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
West China Second University Hospital
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.